4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists

Details for Australian Patent Application No. 2004251825 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Gijsen, Henricus Jacobus Maria; Mevellec, Laurence Anne; Bosmans, JeanPaul Rene Marie Andre

Agent Shelston IP

Pub. Number AU-B-2004251825

PCT Pub. Number WO2005/000838

Priority PCT/EP03/50236 19.06.03 EP

Filing date 10 June 2004

Wipo publication date 6 January 2005

Acceptance publication date 26 November 2009

International Classifications

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/453 (2006.01)

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/000838 Priority application(s): WO2005/000838

26 November 2009 Application Accepted

  Published as AU-B-2004251825

25 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251827-Process for preparing acylsulfamoylbenzamides

2004251823-Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists